NatureCell Co.,Ltd.

Equities

A007390

KR7007390008

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 13/05/2024 BST 5-day change 1st Jan Change
9,740 KRW +1.46% Intraday chart for NatureCell Co.,Ltd. +0.10% +21.90%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
NatureCell Co.,Ltd. announced that it has received KRW 5 billion in funding CI
NatureCell to Raise 5 Billion Won via Stock Sale MT
NatureCell Co.,Ltd. announced that it expects to receive KRW 5 billion in funding CI
NatureCell Co.,Ltd. announced that it has received KRW 11 billion in funding CI
NatureCell to Raise 11 Billion Won in Stock Sale; Shares Rise 3% MT
NatureCell Co.,Ltd. announced that it expects to receive KRW 11 billion in funding CI
NatureCell Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NatureCell Co.,Ltd. announced that it has received KRW 30 billion in funding CI
NatureCell Co.,Ltd. announced that it expects to receive KRW 30 billion in funding CI
R Bio Co.,Ltd. agreed to acquire 9.01% stake in NatureCell Co.,Ltd. from Biostar Korea Co., Ltd. CI
NatureCell Co.,Ltd. announced that it has received KRW 10 billion in funding CI
NatureCell Co.,Ltd. announced that it expects to receive KRW 10 billion in funding CI
NatureCell Co.,Ltd. cancelled the acquisition of 2.3% stake in JASC Co., Ltd. CI
NatureCell Co.,Ltd. agreed to acquire additional 2.3% stake in JASC Co., Ltd. for KRW 1.8 billion. CI
Nature Cell Starts Commercial Clinical Trials Phase I and II ‘ASTROSTEM,’ Stem Cell Drug for Alzheimer's Disease Treatment in U.S CI
Nature Cell Co.,Ltd. Receives U.S. FDA Approval for Phase I and II Alzheimer's Clinical Trial CI
NatureCell Co.,Ltd.(KOSDAQ:A007390) added to S&P Global BMI Index CI
Nature Cell Co.,Ltd. announced that it has received KRW 5 billion in funding CI
Nature Cell Co.,Ltd. announced that it expects to receive KRW 5 billion in funding CI
Sejong Life Science Laboratory sold 0.09% stake in Nature Cell Co.,Ltd. for approximately KRW 230 million. CI
An unknown buyer acquired 0.07% stake in Nature Cell Co.,Ltd. from Sejong Life Science Laboratory for approximately KRW 180 million. CI
Biostar Korea Co., Ltd. acquired additional 8.9% stake in Nature Cell Co.,Ltd. from K-STECMCELL Co.,Ltd. for KRW 27 billion. CI
R Bio Co.,Ltd. announced that it has received KRW 13 billion in funding from NatureCell Co.,Ltd. CI
K-STECMCELL CO.,Ltd. announced that it expects to receive KRW 14.5 billion in funding from Nature Cell Co.,Ltd. and other investors. CI
Nature Cell Co.,Ltd. announced that it has received KRW 2.3 billion in funding from New Pride Corporation. CI
Chart NatureCell Co.,Ltd.
More charts
NatureCell Co Ltd is a Korea-based company principally engaged in the stem cell business. The Company operates its business through three segments. The Stem Cell Business segment is engaged in the development of stem cell therapeutics, the manufacture of stem cell culture media, the development and sale of stem cell culture cosmetics, and the provision of blood cell storage services, among others. The Food Business segment is engaged in the manufacture and sale of fruit beverages including tomato juice, peach juice and others, canned beverages such as sikhye, fruit concentrates and others, as well as fermentation and health functional foods. The Hygiene Business segment is engaged in the manufacture and sale of health hygiene products such as masks, disinfectants, wipes, and others.
More about the company
  1. Stock Market
  2. Equities
  3. A007390 Stock
  4. News NatureCell Co.,Ltd.
  5. NatureCell to Raise 5 Billion Won via Stock Sale